Skip to main content
Clinical Trials/NCT02830893
NCT02830893
Completed
Not Applicable

Lever Actuated Rehabilitation of the Arm Using Wheelchair Propulsion and Computer Gaming

University of California, Irvine1 site in 1 country23 target enrollmentFebruary 15, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebrovascular Accident
Sponsor
University of California, Irvine
Enrollment
23
Locations
1
Primary Endpoint
Fugl-Meyer (FM) Motor Assessment of the Upper Extremity
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study will test the effectiveness of a new lever drive wheelchair, LARA - Lever Actuated Resonance Assistance. LARA facilitates patients in performing a high amount of practice using their moderate to severely impaired upper extremity after stroke.

Investigators will recruit 44 subjects with subacute strokes to participate in the study through the acute rehabilitation unit of the UC Irvine Douglas Hospital. Study participants will be randomized into 2 groups: LARA therapy group or standard therapy group. The LARA therapy group will use LARA to propel themselves to therapy appointments in the unit and to play video games with the affected upper extremity for 30 mins / day. The standard therapy group will use a standard wheelchair to propel themselves using their unaffected upper and lower extremities. They will be asked to perform a matched duration of standard arm exercises for 30 mins/ day. This program of standard arm exercises was developed by an OT at the Rehabilitation Institute of Chicago which consists of graded-difficulty table-supported exercises.

This study will have 3 assessment visits: baseline, 3 weeks after therapy or upon discharge from the acute rehabilitation unit if sooner, and a 3-month follow up.

Registry
clinicaltrials.gov
Start Date
February 15, 2017
End Date
January 10, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Steven C. Cramer, MD

Professor of Neurology

University of California, Irvine

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years at the time of enrollment
  • Stroke onset 1-4 weeks prior to study enrollment
  • Arm motor FM score of \< 30 (out of 66) at Baseline Visit
  • Absence of moderate to severe shoulder pain ( Score \<3 on the 10 point visual analog pain scale)
  • Any deficit in vision, alertness, language, attention, or other cognitive functions that interfere with playing the LARA games

Exclusion Criteria

  • Age \>80 years at the time of enrollment
  • Severe tone in the affected upper extremities (Score ≥ 4 on the Modified Ashworth Spasticity Scale)
  • Severe language problem that would prevent participants from properly understanding instructions
  • Severe reduced level of consciousness
  • Severe aphasia (score of 3 on the NIH stroke scale (question 9))
  • Severe loss of sensation in stroke-affected upper extremities (Score \< 1 on the Nottingham sensory assessment)
  • Currently pregnant
  • Difficulty in understanding or complying with the instructions given by the experimenter
  • Inability to perform the experimental task that will be studied

Outcomes

Primary Outcomes

Fugl-Meyer (FM) Motor Assessment of the Upper Extremity

Time Frame: Baseline, Post-intervention evaluation at 3 weeks, and 3-month evaluation after the end of intervention

We measure the change of the Fugl-Meyer Motor Assessment scores from the baseline evaluation to the 3-month follow up evaluation after the end of intervention. Fugl-Meyer is a 66-point scale measuring the movement pattern of the upper extremities. For the study, we analyze the total score only. The higher scores indicate a better outcome.

Secondary Outcomes

  • Timed 10-meter Walk(Baseline, Post-intervention evaluation at 3 weeks, and 3-months after the end of intervention)
  • Modified Ashworth Spasticity Scale(Baseline, Post-intervention evaluation at 3 weeks, and 3-months after the end of intervention)
  • Box and Blocks Test(Baseline, Post-intervention evaluation at 3 weeks, and 3-months after the end of intervention)

Study Sites (1)

Loading locations...

Similar Trials